Hsbc Holdings PLC Dr Reddys Laboratories LTD Transaction History

Hsbc Holdings PLC

$176 Billion
Q3 2025

A detailed history of Hsbc Holdings PLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Hsbc Holdings PLC holds 189,444 shares of RDY stock, worth $2.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

189,444

Previous 91,560 106.91%

Holding current value

$2.64 Million

Previous $1.38 Million 92.44%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$13.33 - $15.08 $1.3 Million - $1.48 Million	97,884 Added 106.91%	189,444 $2.65 Million
Q4 2024 Feb 14, 2025	BUY	$13.99 - $79.75 $757,600 - $4.32 Million	54,153 Added 144.77%	91,560 $1.45 Million
Q2 2024 Aug 12, 2024	SELL	$68.26 - $76.19 $22,867 - $25,523	-335 Reduced 0.89%	37,407 $2.85 Million
Q1 2024 May 15, 2024	BUY	$67.36 - $77.59 $363,744 - $418,986	5,400 Added 16.7%	37,742 $2.77 Million
Q3 2023 Nov 13, 2023	SELL	$61.9 - $72.77 $1.08 Million - $1.27 Million	-17,389 Reduced 34.97%	32,342 $2.16 Million

Q2 2023 Aug 11, 2023	BUY	$53.34 - $63.11 $176,022 - $208,263	3,300 Added 7.11%	49,731 $3.14 Million
Q1 2023 May 15, 2023	SELL	$51.63 - $56.93 $467,767 - $515,785	-9,060 Reduced 16.33%	46,431 $2.64 Million
Q4 2022 Feb 14, 2023	BUY	$51.15 - $57.45 $1.57 Million - $1.76 Million	30,644 Added 123.33%	55,491 $2.87 Million
Q3 2022 Nov 14, 2022	BUY	$49.9 - $57.32 $54,890 - $63,052	1,100 Added 4.63%	24,847 $1.3 Million
Q1 2022 May 16, 2022	SELL	$48.27 - $65.25 $1,834 - $2,479	-38 Reduced 0.16%	23,747 $1.32 Million
Q4 2021 Feb 11, 2022	SELL	$59.5 - $67.25 $12,733 - $14,391	-214 Reduced 0.89%	23,785 $1.56 Million
Q3 2021 Nov 12, 2021	SELL	$60.19 - $75.29 $132,418 - $165,638	-2,200 Reduced 8.4%	23,999 $1.56 Million
Q2 2021 Aug 13, 2021	SELL	$62.12 - $74.2 $263,388 - $314,608	-4,240 Reduced 13.93%	26,199 $1.93 Million
Q1 2021 May 14, 2021	BUY	$57.98 - $73.08 $908,836 - $1.15 Million	15,675 Added 106.17%	30,439 $1.87 Million
Q4 2020 Feb 12, 2021	SELL	$62.61 - $71.29 $147,133 - $167,531	-2,350 Reduced 13.73%	14,764 $1.05 Million
Q3 2020 Nov 12, 2020	BUY	$51.39 - $72.41 $149,544 - $210,713	2,910 Added 20.49%	17,114 $1.19 Million
Q2 2020 Aug 14, 2020	SELL	$39.55 - $54.65 $29,148 - $40,277	-737 Reduced 4.93%	14,204 $753,000
Q1 2020 May 15, 2020	SELL	$34.75 - $45.85 $696,042 - $918,375	-20,030 Reduced 57.28%	14,941 $603,000
Q4 2019 Feb 14, 2020	BUY	$36.66 - $41.78 $9,421 - $10,737	257 Added 0.74%	34,971 $1.42 Million
Q3 2019 Nov 14, 2019	SELL	$34.82 - $39.26 $225,563 - $254,326	-6,478 Reduced 15.73%	34,714 $1.32 Million
Q2 2019 Aug 13, 2019	BUY	$36.05 - $42.76 $285,407 - $338,530	7,917 Added 23.79%	41,192 $1.54 Million
Q1 2019 May 15, 2019	SELL	$35.77 - $40.57 $65,137 - $73,877	-1,821 Reduced 5.19%	33,275 $1.35 Million
Q4 2018 Feb 13, 2019	BUY	$31.89 - $38.44 $252,664 - $304,560	7,923 Added 29.16%	35,096 $1.32 Million
Q3 2018 Nov 13, 2018	BUY	$29.25 - $36.73 $47,443 - $59,576	1,622 Added 6.35%	27,173 $940,000
Q2 2018 Aug 10, 2018	SELL	$28.49 - $35.06 $140,284 - $172,635	-4,924 Reduced 16.16%	25,551 $822,000
Q1 2018 May 11, 2018	BUY	$31.93 - $39.54 $5,332 - $6,603	167 Added 0.55%	30,475 $996,000
Q4 2017 Feb 14, 2018	SELL	$34.15 - $37.62 $11.1 Million - $12.3 Million	-325,679 Reduced 91.49%	30,308 $1.14 Million
Q3 2017 Nov 14, 2017	SELL	$30.11 - $37.72 $8.51 Million - $10.7 Million	-282,603 Reduced 44.25%	355,987 $12.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	638,590	638,590 $26.9 Million

Others Institutions Holding RDY

# of Institutions

250

Shares Held

94.4M

Call Options Held

Put Options Held

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.31B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Dr Reddys Laboratories LTD Transaction History